Riskpilot← Back to searchSign inGet full accessDeBri Medical AB
ABActiveOrg 5567135446Vårgärdsvägen 64General medical practice activities · NACE 8621Est. 20061-4 employees
Revenue 2024
SEK 3,9M
+26% vs 2023
EBITDA margin
-13.3%
+64% vs 2023
Equity ratio
83.1%
Financial strength
Net profit 2024
SEK -270K
-940% vs 2023
| Revenue | SEK 3,9M | +26% |
| EBITDA | SEK -523K | +64% |
| Net profit | SEK -270K | -940% |
| Total assets | SEK 2,1M | -50% |
| Equity | SEK 1,7M | -14% |
| Employees | — | — |
Legal name
DeBri Medical AB
Org number
5567135446
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 oktober 2006
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva tand, hälso- och sjukvård och konsultationer inom dessa områden samt därmed förenlig verksamhet.
Address
Vårgärdsvägen 64
Phone
+4686111250
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 010 | 2 441 | 2 591 | 3 130 | 3 935 |
| Staff expenses | — | — | −2 146 | −2 226 | −2 358 |
| EBITDA | −1 702 | −1 512 | −1 311 | −1 454 | −523 |
| Depreciation & amort. | −102 | −133 | −179 | −163 | −170 |
| EBIT | −1 804 | −1 645 | −1 491 | −1 617 | −692 |
| Net financials | 366 | 319 | 253 | 256 | 22 |
| Profit before tax | −149 | 174 | −34 | 5 | −270 |
| Tax | −0 | −57 | −13 | −31 | — |
| Net profit | −149 | 117 | −47 | −26 | −270 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 241 | 8 670 | 6 526 | 4 172 | 2 073 |
| Equity | 4 649 | 4 766 | 3 219 | 1 993 | 1 723 |
| Long-term debt | 0 | 0 | 140 | 0 | — |
| Short-term debt | 1 122 | 934 | 1 401 | 1 779 | 350 |
| Total debt | 1 122 | 934 | 1 541 | 1 779 | 350 |
EBITDA margin
-13.3%
This company
15.8%
Market median
-184% vs market
20202024
Equity ratio
83.1%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
-15.7%
This company
18.4%
Market median
-185% vs market
20202024
Net profit margin
-6.9%
This company
8.1%
Market median
-185% vs market
20202024
Asset turnover
1.90×
This company
1.12×
Market median
+70% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AG | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DeBri Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Gabriel Lundgren | Audit | 0 companies |
| Edin Stefano De Bri | Board of Directors | 0 companies |
| Karin Elisabeth Hallqvist De Bri | Deputy Board Member | 0 companies |